| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Creativity and Innovation Management - Competition versus Collaboration |
|
Main Subject - Creativity and Innovation Management - Competition versus Collaboration
There is much confusion as to whether competition or collaboration is most beneficial to creativity and innovation. Though there are According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product negatives to collaboration and it is not easy separating the effects of time pressure and group activity, in general collaboration ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in beats competition. This article will set out some of the arguments. a) Competition forces some individuals to produce a greater num lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ber of ideas than they would do otherwise. But crucially, competition forces other people to shut down. Exactly who raises their g here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ame and who shuts down depends on the game, the rules, the competencies, the level of evaluation anxiety and other factors. People c d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro hoose which areas they want to compete in. b) When forced to produce, through competition, people are more likely to be non-synergi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc stically extrinsically motivated – that is they may produce to fulfil an ulterior motive but the activity leaves them feeling contro easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi lled and dependent and they do not tend to engage in the task to the degree necessary for rich insights. c) Competition causes indi nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically viduals to withhold information and thus reduces the degree of intellectual cross-pollination, networking and collaboration required and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ to achieve the best ideas. d) Most competition doesn’t allow the mind to incubate problems long enough for truly rich insights to ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi emerge. Some of the richest insights have occurred when the individual is distant from the problem, rested and engaged in unrelated ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a activities. e) Competition increases evaluation apprehension, which causes a reduction of expression and lower risk taking and high dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod er levels of conformity. This is not conducive to good idea generation. f) Competition causes individuals to generate ideas accordi cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ng to the value system indicated at the start, reducing lateral thinking, decreasing the number of diverse and novel ideas and lower tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ing the separation of creative from critical thinking. g) Collaboration is much more valuable during the innovation stage (idea sel t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ection, development and commercialisation), where the competencies of many people are required to successfully commercialise. These ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust topics are covered in depth in the MBA dissertation on Managing Creativity & Innovation, which can be purchased (along with a Creat y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ivity and Innovation DIY Audit, Good Idea Generator Software and Power Point Presentation) from http://www.managing-creativity.com. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de You can also receive a regular, free newsletter by entering your email address at this site. Kal Bishop, MBA ********************* elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ************* You are free to reproduce this article as long as no changes are made and the author's name and site URL are retained tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Delighting Customers - Three Solutions to Make the Difference Make Money Buying Books - The Ten Golden Rules Employee Performance Issues - How to Effectively Address Problem Performance
|